VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd

<< Previous

Bullboard Posts

Next >>

Post by jopatcloon Oct 13, 2024 7:17pm

77 Views

Post# 36264831

BSEcho 2024📅 the role of AI in Echo 👀post Hannah Crane 👏

Dario Freitas commented on this

Second day of the British Society Of Echocardiography Conference in Edinburgh! Great day yesterday - my highlight had to be Dr Maria Paton’s insights into a year in echo research!
Today’s must-attend session is for me is the Congenital Heart Disease session on AVSDs and also the international speaker Dr Victoria Delgado who will be talking about the role of AI in Echo